{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:32:26Z","timestamp":1786365146575,"version":"build-2736575974"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008541","name":"University of Baghdad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008541","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.intimp.2024.112776","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T14:06:12Z","timestamp":1722261972000},"page":"112776","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["mRNA vaccination reduces the thrombotic possibility in COVID-19: Inflammation risk estimates"],"prefix":"10.1016","volume":"140","author":[{"given":"Marwah Raad","family":"Al-Sammarraie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha Raad","family":"Al-Sammarraie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Azaiez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab M.M.","family":"Al-Rubae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hejer","family":"Litaiem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser M.","family":"Taay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9159","key":"10.1016\/j.intimp.2024.112776_b0005","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(98)10266-0","article-title":"Venous thrombosis: a multicausal disease","volume":"353","author":"Rosendaal","year":"1999","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.intimp.2024.112776_b0010","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/ATVBAHA.114.304488","article-title":"Thrombosis","volume":"34","author":"Raskob","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.intimp.2024.112776_b0015","first-page":"375","article-title":"Etiology and complications of portal vein thrombosis","volume":"30","author":"Trebicka","year":"2014","journal-title":"Viszeralmedizin."},{"key":"10.1016\/j.intimp.2024.112776_b0020","unstructured":"J.M. Ferro, P. Canh\u00e3o, S. Kasner, R. Goddeau Jr, Cerebral venous thrombosis: Etiology, clinical features, and diagnosis, UpToDate [database on the internet]. Waltham, UpToDate, 2019."},{"issue":"1","key":"10.1016\/j.intimp.2024.112776_b0025","doi-asserted-by":"crossref","first-page":"15006","DOI":"10.1038\/nrdp.2015.6","article-title":"Venous thrombosis","volume":"1","author":"Wolberg","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"5","key":"10.1016\/j.intimp.2024.112776_b0030","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1631\/jzus.B2000083","article-title":"An overview of COVID-19","volume":"21","author":"Shi","year":"2020","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"10.1016\/j.intimp.2024.112776_b0035","article-title":"Global data analysis and risk factors associated with morbidity and mortality of COVID-19","volume":"26","author":"Tazerji","year":"2022","journal-title":"Gene Rep."},{"issue":"1","key":"10.1016\/j.intimp.2024.112776_b0040","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jmv.26232","article-title":"The cytokine storm and COVID-19","volume":"93","author":"Hu","year":"2021","journal-title":"J. Med. Virol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112776_b0045","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3390\/pathogens11020195","article-title":"The Association between TNF-\u03b1, IL-6, and Vitamin D Levels and COVID-19 severity and mortality: a systematic review and meta-analysis","volume":"11","author":"Halim","year":"2022","journal-title":"Pathogens"},{"issue":"3","key":"10.1016\/j.intimp.2024.112776_b0050","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/MCP.0000000000000859","article-title":"COVID-19 and other respiratory tract infections at mass gathering religious and sporting events","volume":"28","author":"Al-Tawfiq","year":"2022","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"12","key":"10.1016\/j.intimp.2024.112776_b0055","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/ajh.25982","article-title":"Thrombosis in COVID-19","volume":"95","author":"Hanff","year":"2020","journal-title":"Am. J. Hematol."},{"issue":"6","key":"10.1016\/j.intimp.2024.112776_b0060","first-page":"348","article-title":"Review of cellular and molecular pathways linking thrombosis and innate immune system during sepsis","volume":"15","author":"Konecny","year":"2010","journal-title":"J. Res. Med. sciences: Off. J. Isfahan University of Med. Sci."},{"key":"10.1016\/j.intimp.2024.112776_b0065","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s40256-020-00431-z","article-title":"Current overview on hypercoagulability in COVID-19","volume":"20","author":"Singhania","year":"2020","journal-title":"Am. J. Cardiovasc. Drugs"},{"issue":"1","key":"10.1016\/j.intimp.2024.112776_b0070","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11239-014-1101-6","article-title":"d-Dimer elevation and adverse outcomes","volume":"39","author":"Halaby","year":"2015","journal-title":"J. Thromb. Thrombol."},{"issue":"11","key":"10.1016\/j.intimp.2024.112776_b0075","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1080\/17474086.2020.1831383","article-title":"D-dimer level in COVID-19 infection: a systematic review","volume":"13","author":"Rostami","year":"2020","journal-title":"Expert Rev. Hematol."},{"issue":"5","key":"10.1016\/j.intimp.2024.112776_b0080","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1515\/cclm-2022-0633","article-title":"D-dimer: old dogmas, new (COVID-19) tricks","volume":"61","author":"Lippi","year":"2023","journal-title":"Clinical Chemistry and Laboratory Medicine (CCLM)"},{"issue":"7","key":"10.1016\/j.intimp.2024.112776_b0085","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1046\/j.1538-7836.2003.00261.x","article-title":"Inflammation and thrombosis","volume":"1","author":"Esmon","year":"2003","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.intimp.2024.112776_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2022.108336","article-title":"Post-COVID syndrome, inflammation, and diabetes","author":"Rizvi","year":"2022","journal-title":"J. Diabetes Complications"},{"issue":"5","key":"10.1016\/j.intimp.2024.112776_b0095","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/annrheumdis-2011-200468","article-title":"Combination of IL-17 and TNF\u03b1 induces a pro-inflammatory, pro-coagulant and pro-thrombotic phenotype in human endothelial cells","volume":"71","author":"Hot","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2024.112776_b0100","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3389\/fmed.2018.00147","article-title":"Cytokines, adhesion molecules, and matrix metalloproteases as predisposing, diagnostic, and prognostic factors in venous thrombosis","volume":"5","author":"Mosevoll","year":"2018","journal-title":"Front. Med."},{"key":"10.1016\/j.intimp.2024.112776_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2021.104799","article-title":"The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?","volume":"153","author":"Darif","year":"2021","journal-title":"Microb. Pathog."},{"issue":"2","key":"10.1016\/j.intimp.2024.112776_b0110","doi-asserted-by":"crossref","first-page":"327","DOI":"10.23812\/CONTI-E","article-title":"Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies","volume":"34","author":"Conti","year":"2020","journal-title":"J. Biol. Regul. Homeost. Agents"},{"issue":"5","key":"10.1016\/j.intimp.2024.112776_b0115","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3390\/vaccines9050436","article-title":"Role of inflammatory cytokines in COVID-19 patients: a review on molecular mechanisms, immune functions, immunopathology and immunomodulatory drugs to counter cytokine storm","volume":"9","author":"Rabaan","year":"2021","journal-title":"Vaccines"},{"issue":"8","key":"10.1016\/j.intimp.2024.112776_b0120","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1371\/journal.pmed.0030334","article-title":"Inflammatory cytokines as risk factors for a first venous thrombosis: a prospective population-based study","volume":"3","author":"Christiansen","year":"2006","journal-title":"PLoS Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.112776_b0125","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/jlb.59.1.67","article-title":"Human monocyte chemotactic proteins-2 and -3: structural and functional comparison with MCP-1","volume":"59","author":"Proost","year":"1996","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112776_b0130","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1006\/bbrc.1993.1251","article-title":"Human monocyte chemotactic protein-3 (MCP-3): molecular cloning of the cDNA and comparison with other chemokines","volume":"191","author":"Opdenakker","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.intimp.2024.112776_b0135","first-page":"554","article-title":"Monocyte chemotactic protein-3","volume":"12","author":"Menten","year":"2001","journal-title":"Eur. Cytokine Netw."},{"issue":"1","key":"10.1016\/j.intimp.2024.112776_b0140","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jaci.2020.04.027","article-title":"Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19","volume":"146","author":"Yang","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112776_b0145","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/s41392-020-00433-y","article-title":"Scoring cytokine storm by the levels of MCP-3 and IL-8 accurately distinguished COVID-19 patients with high mortality","volume":"5","author":"Chen","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.intimp.2024.112776_b0150","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s11239-020-02235-z","article-title":"Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis","volume":"50","author":"Hasan","year":"2020","journal-title":"J. Thromb. Thrombol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112776_b0155","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1615\/CritRevEukarGeneExpr.v20.i2.10","article-title":"Tumor necrosis factor-\u03b1 signaling in macrophages","volume":"20","author":"Parameswaran","year":"2010","journal-title":"Crit. Rev. Eukaryot Gene. Expr."},{"key":"10.1016\/j.intimp.2024.112776_b0160","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.866751","article-title":"Thrombosis and Inflammation\u2014A dynamic interplay and the role of glycosaminoglycans and activated protein C","volume":"9","author":"Kohli","year":"2022","journal-title":"Front. Cardiovascular Med."},{"issue":"9","key":"10.1016\/j.intimp.2024.112776_b0165","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11883-020-00867-3","article-title":"Lipoprotein(a) and its potential association with thrombosis and inflammation in COVID-19: a Testable Hypothesis","volume":"22","author":"Moriarty","year":"2020","journal-title":"Curr. Atheroscler. Rep."},{"issue":"2","key":"10.1016\/j.intimp.2024.112776_b0170","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.biocel.2004.06.017","article-title":"MMP-1: the elder of the family","volume":"37","author":"Pardo","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"5","key":"10.1016\/j.intimp.2024.112776_b0175","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1172\/JCI45666","article-title":"MMP-1 drives immunopathology in human tuberculosis and transgenic mice","volume":"121","author":"Elkington","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.intimp.2024.112776_b0180","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/infdis\/jiab167","article-title":"Excessive matrix metalloproteinase-1 and hyperactivation of endothelial cells occurred in COVID-19 patients and were associated with the severity of COVID-19","volume":"224","author":"Syed","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.intimp.2024.112776_b0185","doi-asserted-by":"crossref","DOI":"10.3390\/biom11030390","article-title":"Targeting MMP-regulation of inflammation to increase metabolic tolerance to COVID-19 pathologies: a hypothesis","author":"Hardy","year":"2021","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.intimp.2024.112776_b0190","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4155\/tde-2020-0129","article-title":"An overview of vaccine development for COVID-19","volume":"12","author":"Shahcheraghi","year":"2021","journal-title":"Ther. Deliv."},{"issue":"34","key":"10.1016\/j.intimp.2024.112776_b0195","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.15585\/mmwr.mm7034e2","article-title":"Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021","volume":"70","author":"Tenforde","year":"2021","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"issue":"9","key":"10.1016\/j.intimp.2024.112776_b0200","doi-asserted-by":"crossref","first-page":"701","DOI":"10.5588\/ijtld.21.0298","article-title":"Thrombotic events and COVID-19 vaccines","volume":"25","author":"Brazete","year":"2021","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.intimp.2024.112776_b0205","doi-asserted-by":"crossref","unstructured":"P.R. Hunter, Thrombosis after covid-19 vaccination,2021, British Medical Journal Publishing Group.","DOI":"10.1136\/bmj.n958"},{"key":"10.1016\/j.intimp.2024.112776_b0210","article-title":"Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study","volume":"374","author":"Hippisley-Cox","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.intimp.2024.112776_b0215","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.thromres.2020.05.039","article-title":"Thrombosis risk associated with COVID-19 infection. A scoping review","volume":"192","author":"Al-Ani","year":"2020","journal-title":"Thromb. Res."},{"key":"10.1016\/j.intimp.2024.112776_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100745","article-title":"Coagulation dysfunction in COVID-19: the interplay between inflammation, viral infection and the coagulation system","volume":"46","author":"Lazzaroni","year":"2021","journal-title":"Blood Rev."},{"issue":"47","key":"10.1016\/j.intimp.2024.112776_b0225","doi-asserted-by":"crossref","first-page":"48487","DOI":"10.1074\/jbc.R400025200","article-title":"C-reactive protein","volume":"279","author":"Black","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2024.112776_b0230","doi-asserted-by":"crossref","DOI":"10.1177\/20503121211050755","article-title":"The role of C-reactive protein in predicting the severity of COVID-19 disease: a systematic review","volume":"9","author":"Yitbarek","year":"2021","journal-title":"SAGE Open Medicine."},{"key":"10.1016\/j.intimp.2024.112776_b0235","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1002652","article-title":"C-reactive protein, immunothrombosis and venous thromboembolism","volume":"13","author":"Dix","year":"2022","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2024.112776_b0240","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.medmal.2020.03.007","article-title":"C-reactive protein levels in the early stage of COVID-19","volume":"50","author":"Wang","year":"2020","journal-title":"Med. Mal. Infect."},{"issue":"23","key":"10.1016\/j.intimp.2024.112776_b0245","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1093\/eurheartj\/ehaa1103","article-title":"C-reactive protein and clinical outcomes in patients with COVID-19","volume":"42","author":"Smilowitz","year":"2021","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.intimp.2024.112776_b0250","article-title":"The study of biomarkers in patients who were re-infected With COVID-19 after being vaccinated With (Pfizer or Sinopharm) vaccine in Basra, Iraq","volume":"4","author":"Ahmed Jihad","year":"2023","journal-title":"Central Asian J. Med. Natural Sci."},{"key":"10.1016\/j.intimp.2024.112776_b0255","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.794642","article-title":"Reactogenicity and immunogenicity of the Pfizer and AstraZeneca COVID-19 vaccines","volume":"12","author":"Mahallawi","year":"2021","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2024.112776_b0260","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21061920","article-title":"From classical laboratory parameters to novel biomarkers for the diagnosis of venous thrombosis","volume":"21","author":"Anghel","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.112776_b0265","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.thromres.2020.09.017","article-title":"Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients","volume":"196","author":"Dujardin","year":"2020","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.intimp.2024.112776_b0270","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1111\/bjh.16797","article-title":"Dynamic relationship between D-dimer and COVID-19 severity","volume":"190","author":"Li","year":"2020","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.intimp.2024.112776_b0275","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1219502","article-title":"Effect of domestic COVID-19 vaccine on the plasma D-dimer levels of early pregnant women in China","volume":"10","author":"Liang","year":"2023","journal-title":"Front. Med."},{"key":"10.1016\/j.intimp.2024.112776_b0280","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.avsg.2022.05.001","article-title":"Thromboembolism after Covid-19 vaccination: a systematic review of such events in 286 patients","volume":"84","author":"Mani","year":"2022","journal-title":"Ann. Vasc. Surg."},{"issue":"4","key":"10.1016\/j.intimp.2024.112776_b0285","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.arcmed.2022.03.008","article-title":"Increment of D-dimer associated with immune thrombotic thrombocytopenia in ChAdOx1 nCoV-19 vaccinated individuals","volume":"53","author":"Ornelas-Aguirre","year":"2022","journal-title":"Arch. Med. Res."},{"issue":"9","key":"10.1016\/j.intimp.2024.112776_b0290","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/cts.13569","article-title":"Anticoagulant therapy in COVID-19: a narrative review","volume":"16","author":"Mohseni Afshar","year":"2023","journal-title":"Clin. Transl. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2024.112776_b0295","article-title":"Multidisciplinary diagnostic approach for fulminant myocarditis related to coronavirus disease 2019 messenger RNA vaccines: a case report","volume":"7","author":"Fujii","year":"2023","journal-title":"Eur. Heart J. - Case Rep."},{"issue":"1","key":"10.1016\/j.intimp.2024.112776_b0300","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/jmv.26156","article-title":"Circulating levels of IL-2, IL-4, TNF-\u03b1, IFN-\u03b3, and C-reactive protein are not associated with severity of COVID-19 symptoms","volume":"93","author":"Luo","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.intimp.2024.112776_b0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.micinf.2023.105179","article-title":"COVID-19 patients with high TNF\/IFN-\u03b3 levels show hallmarks of PANoptosis, an inflammatory cell death","author":"Palacios","year":"2023","journal-title":"Microbes Infect."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924012979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924012979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:05:31Z","timestamp":1786363531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924012979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":61,"alternative-id":["S1567576924012979"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112776","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"mRNA vaccination reduces the thrombotic possibility in COVID-19: Inflammation risk estimates","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112776","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112776"}}